Literature DB >> 23408786

Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov.

Sahare Kokcha1, Dhamodharan Ramasamy, Jean-Christophe Lagier, Catherine Robert, Didier Raoult, Pierre-Edouard Fournier.   

Abstract

Brevibacterium senegalense strain JC43(T) sp. nov. is the type strain of Brevibacterium senegalense sp. nov., a new species within the Brevibacterium genus. This strain, whose genome is described here, was isolated from the fecal flora of a healthy Senegalese patient. B. senegalense is an aerobic rod-shaped Gram-positive bacterium. Here we describe the features of this organism, together with the complete genome sequence and annotation. The 3,425,960 bp long genome (1 chromosome but no plasmid) contains 3,064 protein-coding and 49 RNA genes.

Entities:  

Keywords:  Brevibacterium senegalense; genome

Year:  2012        PMID: 23408786      PMCID: PMC3569389          DOI: 10.4056/sigs.3256677

Source DB:  PubMed          Journal:  Stand Genomic Sci        ISSN: 1944-3277


Introduction

strain JC43T (= CSUR P155 = DSM 25783) is the type strain of B. senegalense. sp. nov. This bacterium is a non-motile, rod-shaped, Gram-positive, catalase-positive bacterium that was isolated from the stool of a healthy Senegalese patient as part of a study aiming at cultivating individually all bacterial species within human feces. Bacterial taxonomy has undergone many changes over recent years. The DNA-DNA hybridization and G+C content criteria, once considered as gold standards [1], were gradually replaced by gene sequencing. In particular, 16S rRNA sequencing has deeply changed the way bacteria and archaea are classified [2]. More recently, the development of high throughput genome sequencing methods and mass spectrometric analyses of bacteria have provided a wealth of genetic and proteomic information [3]. We recently used a polyphasic approach [4] that includes genomic data, MALDI-TOF spectrum and major phenotypic characteristics to describe new bacterial species [5-11]. The genus (Breed 1953) [12] was created in 1953 to gather short non-spore-forming and non-branching rods. To date, this genus is comprised of Gram-positive, irregular, rod-shaped, non-acid-fast bacteria, and contains 31 recognized species with validly published names [13]. is the type genus of the family (Breed 1953) [14]. Members of the genus are isolated from human samples, dairy products, poultry and environmental specimens. In humans, they are found on skin surfaces [15], but have also been demonstrated to cause rare cases of bacteremia, endocarditis, pericarditis, brain abscess and peritonitis. These infections have been observed mainly in immunocompromised patients, with the exception of two cases of bacteremia in immunocompetent patients with central venous catheters [15,16]. To date, only four species have been detected in human infection, including (Collins et al. 1983) [15,17,18], (Collins et al. 1983) [16,19], (Collins et al. 1981) and (Pascual et al. 1996). Here we present a summary classification and a set of features for B. senegalense sp. nov. strain JC43T together with the description of the complete genomic sequencing and annotation. These characteristics support the circumscription of the B. senegalense species.

Organism information

A stool sample was collected from a healthy 16-year-old male Senegalese volunteer patient living in Dielmo (rural village in the Guinean-Sudanian zone in Senegal), who was included in a research protocol. Written assent was obtained from this individual. No written consent was needed from his guardians for this study because he was older than 15 years old (in accordance with the previous project approved by the Ministry of Health of Senegal and the assembled village population, and as published elsewhere [5-11]. Both this study and the assent procedure were approved by the National Ethics Committee of Senegal (CNERS) and the Ethics Committee of the Institut Fédératif de Recherche IFR48, Faculty of Medicine, Marseille, France (agreement numbers 09-022 and 11-017)). Several other new bacterial species were isolated from this specimen using various culture conditions, including the recently described , , , and [5-11]. The fecal specimen was preserved at -80°C after collection and sent to Marseille. Strain JC43T (Table 1) was isolated in December 2010 after inoculation on Brucella agar (BD diagnostic, Heilderberg, Germany), in aerobic atmosphere at 37°C.
Table 1

Classification and general features of strain JC43T according to the MIGS recommendations [20]

MIGS ID    Property     Term     Evidence codea
    Current classification     Domain Bacteria     TAS [21]
     Phylum Actinobacteria     TAS [22]
     Class Actinobacteria     TAS [23]
     Order Actinomycetales     TAS [23-26]
     Family Brevibacteriaceae     TAS [23,24,26,27]
     Genus Brevibacterium     TAS [14,24]
     Species Brevibacterium senegalensis     IDA
     Type strain JC43T     IDA
    Gram stain     positive     IDA
    Cell shape     rod     IDA
    Motility     nonmotile     IDA
    Sporulation     nonsporulating     IDA
    Temperature range     Mesophile     IDA
    Optimum temperature     30 - 37°C     IDA
MIGS-6.3    Salinity     unknown     IDA
MIGS-22    Oxygen requirement     aerobic     IDA
    Carbon source     glucose
    Energy source     chemoorganotrophic
MIGS-6    Habitat     human gut     IDA
MIGS-15    Biotic relationship     free living     IDA
MIGS-14    Pathogenicity    Biosafety level    Isolation     unknown     2     human feces
MIGS-4    Geographic location     Senegal     IDA
MIGS-5    Sample collection time     September 2010     IDA
MIGS-4.1    Latitude –    Longitude     13.7167     -16.4167     IDA
MIGS-4.3    Depth     surface     IDA
MIGS-4.4    Altitude     51 m above sea level     IDA

aEvidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (a direct report exists in the literature); NAS: Non-traceable Author Statement (not directly observed for the living, isolated sample, but based on a generally accepted property of the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [28].

aEvidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (a direct report exists in the literature); NAS: Non-traceable Author Statement (not directly observed for the living, isolated sample, but based on a generally accepted property of the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [28]. The strain exhibited 97.1 and 96.7% nucleotide sequence similarities with (Guan et al. 2010) and (Tang et al. 2008), respectively, the phylogenetically closest validated species (Figure 1). These values were lower than the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers to delineate a new species without carrying out DNA-DNA hybridization [2]. In comparison to 16S sequences in the GenBank database [29], strain JC43T also exhibited nucleotide sequence similarities greater than 98.7% with uncultured bacterial clones detected in water-miscible metalworking fluids [30] and on clean room surfaces [31]. These bacteria most likely belong to the same species as strains JC43 (Figure 1).
Figure 1

Phylogenetic tree highlighting the position of strain JC43T relative to other type strains within the genus . GenBank accession numbers are indicated in parentheses. Sequences were aligned using CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method within the MEGA software. Numbers at the nodes are percentages of bootstrap values obtained by repeating 500 times the analysis to generate a majority consensus tree. The dashed-line square shows sequences that exhibit degrees of similarity > 99% with B. senegalense (same species). Asterisks indicate the species for which genome sequences are currently available.

Phylogenetic tree highlighting the position of strain JC43T relative to other type strains within the genus . GenBank accession numbers are indicated in parentheses. Sequences were aligned using CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method within the MEGA software. Numbers at the nodes are percentages of bootstrap values obtained by repeating 500 times the analysis to generate a majority consensus tree. The dashed-line square shows sequences that exhibit degrees of similarity > 99% with B. senegalense (same species). Asterisks indicate the species for which genome sequences are currently available. Different growth temperatures (25, 30, 37, 45°C) were tested; no growth occurred at 45°C, weak growth occurred at 25°C, and optimal growth was observed between 30 to 37°C. Colonies were translucent and smooth, with a diameter of 1 mm on blood-enriched Columbia agar and Brain Heart Infusion (BHI) agar. Growth of the strain was tested under anaerobic and microaerophilic conditions using GENbag anaer and GENbag microaer systems, respectively (BioMérieux), and in the presence of air, of 5% CO2 and in aerobic conditions. Optimal growth was obtained aerobically and with 5% CO2. Weak growth was observed under microaerophilic conditions. No growth was observed in an anaerobic atmosphere. Gram staining showed Gram-positive rods. A motility test was negative. Cells grown on agar are Gram-positive (Figure 2) and are mostly grouped in small clumps (Figure 3). Their length and width range from 0.83 to 3.86 µm (mean, 2.55 µm) and 0.57 to 0.78 µm (mean, 0.68 µm), respectively.
Figure 2

Gram staining of B. senegalense strain JC43T

Figure 3

Transmission electron microscopy of B. senegalense strain JC43T, using a Morgani 268D (Philips) at an operating voltage of 60kV. The scale bar represents 200 nm.

Gram staining of B. senegalense strain JC43T Transmission electron microscopy of B. senegalense strain JC43T, using a Morgani 268D (Philips) at an operating voltage of 60kV. The scale bar represents 200 nm. Strain JC43T exhibited catalase activity but not oxidase activity. Using the API CORYNE system(BioMérieux), positive reactions were observed for nitrate reduction, pyrrolidonyl arylamidase, alkaline phosphatase, α-glucosidase. A weak reaction was observed for gelatin hydrolysis. Negative reactions were observed for urease, pyrazinamidase, β-glucuronidase, β-galactosidase, α-glucosidase, N-acetyl-β-glucosaminidase, β-glucosidase (aesculin hydrolysis), and acid production from D-ribose, D-glucose, D-xylose, D-mannitol, maltose, D-lactose, sucrose and glycogen. Using API ZYM (BioMérieux), positive reactions were observed for esterase (C4), esterase lipase (C8), leucine arylamidase and acid and alkaline phosphatase. Negative reactions were observed for valine arylamidase, cystine arylamidase, trypsin, α-chymotrypsin, naphtol-AS-BI-phosphohydrolase, lipase, α-galactosidase, β-galactosidase, β-glucuronidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase, α-mannosidase and α-fucosidase. B. senegalense is susceptible to penicillin G, amoxicillin, imipenem, ciprofloxacin, rifampin, gentamicin, doxycycline and vancomycin but resistant to trimethoprim/sulfamethoxazole and metronidazole. By comparison to [32] and [33], B. senegalense strain JC43T differed in growth temperature, gelatin hydrolysis, pyrazinamidase, acid production from D-ribose, and nitrate reduction. In addition, B. senegalense also differed from the former species in β-glucosidase (aesculin hydrolysis) activity [32], and from the latter species in motility, valine arylamidase, cystine arylamidase, trypsin, α-chymotrypsin and naphtol-AS-BI-phosphohydrolase activities [33]. Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) MS protein analysis was carried out as previously described [5,34] using a Microflex spectrometer (Bruker Daltonics, Germany). Twelve distinct deposits were done for strain JC43T from four isolated colonies. The 12 JC43T spectra were imported into the MALDI BioTyper software (version 2.0, Bruker) and analyzed by standard pattern matching (with default parameter settings) against the main spectra of 3,769 bacteria, which were used as reference data, in the BioTyper database. The database contained 41 spectra from 18 validly published species, including . No significant score was obtained for strain JC43, thus suggesting that our isolate was not a member of a known species within the Bruker database. We incremented our database with the spectrum from strain JC43 (Figure 4).
Figure 4

Reference mass spectrum from B. senegalense strain JC43T. Spectra from 4 individual colonies were compared and a reference spectrum was generated.

Reference mass spectrum from B. senegalense strain JC43T. Spectra from 4 individual colonies were compared and a reference spectrum was generated.

Genome sequencing and annotation

Genome project history

The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to other members of the genus, and is part of a study aiming at isolating all bacterial species within human feces. It was the third genome of a species. The genome EMBL accession number is CAHK00000000 and consists of 80 contigs. Table 2 shows the project information and its association with MIGS version 2.0 compliance.
Table 2

Project information

MIGS ID    Property    Term
MIGS-31    Finishing quality    High quality draft
MIGS-28    Libraries used    One shotgun, one paired-end 3-kb
MIGS-29    Sequencing platforms    454 GS FLX Titanium
MIGS-31.2    Fold coverage    20 ×
MIGS-30    Assemblers    Newbler version 2.5.3
MIGS-32    Gene calling method    Prodigal
    EMBL ID    CAHK00000000
    EMBL date of Release    February 2, 2012
    Project relevance    Study of the human gut microbiot

Growth conditions and DNA isolation

B. senegalense sp. nov. strain JC43T (CSUR = P155, DSM = 25783) was grown aerobically on 5% sheep blood-enriched Columbia agar at 37°C. Seven petri dishes were spread and resuspended in 3x100µl of G2 buffer (EZ1 DNA Tissue kit, Qiagen). A first mechanical lysis was performed by glass powder on the Fastprep-24 device (Sample Preparation system; MP Biomedicals, USA) using 2x20 seconds cycles. DNA was then treated with 2.5µg/µL lysozyme (30 minutes at 37°C) and extracted through the BioRobot EZ 1 Advanced XL (Qiagen). The DNA was then concentrated and purified on a Qiamp kit (Qiagen). The yield and the concentration was measured by the Quant-it Picogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 68,1 ng/µl.

Genome sequencing and assembly

A shotgun library and a 3kb paired end library were pyrosequenced on the 454 Roche Titanium sequencing platform. This project was loaded on one 1/4 region region of PTP Picotiterplate (Roche, Meylan, France) for the shotgun library and 4 × 1/4 region for the 3-kb paired-end library. The shotgun library was constructed with 500 ng of DNA with the GS Rapid library Prep kit as described by the manufacturer (Roche). For the paired-end library, 5µg of DNA was mechanically fragmented on a Hydroshear device (Digilab, Holliston, MA, USA) with an enrichment size at 3-4kb. DNA fragmentation was visualized using an Agilent 2100 BioAnalyzer on a DNA labchip 7500 with an optimal size of 3.692 kb. The library was constructed according to the 454 Titanium paired-end protocol (Roche). Circularization and nebulization were performed and generated a pattern with an optimum of 510 bp. After PCR amplification through 15 cycles followed by double size selection, the single stranded paired-end library was then quantified using a Quant-it Ribogreen kit (Invitrogen) on a Genios Tecan fluorometer at 245 pg/µL. The library concentration equivalence was calculated at 8.80E+08 molecules/µL. The libraries were stocked at -20°C until further use. The shotgun library was clonally amplified with 3 cpb in 3 emPCR reactions and the 3-kb paired-end library was amplified with 1 cpb in 10 emPCR reactions and 0.25 cpb in 4 emPCR with the GS Titanium SV emPCR Kit (Lib-L) v2 (Roche). The yield of the shotgun emPCR reactions was higher than expected at 24%, but the yields of the two types of paired-end emPCR were 16.7% and 11.01%, respectively, in the range of 5 to 20% from the Roche procedure. The libraries were loaded on the GS Titanium PicoTiterPlate PTP Kit 70×75 and sequenced with the GS FLX Titanium Sequencing Kit XLR70 (Roche). The runs were performed overnight and then analyzed on the cluster through the gsRunBrowser and Newbler Assembler (Roche). A total of 752,121 passed filter wells were obtained and generated 203.1 Mb of sequence with an average length of 265 bp. The passed filter sequences were assembled using Newbler with 90% identity and 40 bp as overlap. The final assembly identified 80 contigs (>500 bp) arranged into 16 scaffolds and generated a genome size of 3.42 Mb.

Genome annotation

Open Reading Frames (ORFs) were predicted using Prodigal [35] with default parameters but the predicted ORFs were excluded if they were spanning a sequencing GAP region. The predicted bacterial protein sequences were searched against the GenBank database and the Clusters of Orthologous Groups (COG) database using BLASTP. The tRNAScanSE tool [36] was used to find tRNA genes, whereas ribosomal RNAs were found using RNAmmer [37]. Transmembrane domains and signal peptides were predicted using TMHMM [38] and SignalP [39], respectively. ORFans were identified if their BLASTp E-value was lower than 1e-03 for alignment length greater than 80 amino acids. If alignment lengths were smaller than 80 amino acids, we used an E-value of 1e-05. To estimate the mean level of nucleotide sequence similarity at the genome level between B. senegalense, (GenBank accession number AAGP00000000) and (ADNU00000000) we compared the ORFs only using BLASTN at a query coverage of ≥ 70% and a minimum nucleotide length of 100 bp.

Genome properties

The genome is 3,425,960 bp long (1 chromosome, but no plasmid) with a 70.00% G+C content (Table 3 and Figure 5). Of the 3,114 predicted genes, 3,065 were protein-coding genes and 49 were RNAs, including 3 rRNA operons (5S, 16S and 23S rRNA) and 40 tRNAs. A total of 2,077 genes (66.7%) were assigned a putative function. The distribution of genes into COGs functional categories is presented in Table 4 and Figure 5. The properties and the statistics of the genome are summarized in Tables 3 and 4.
Table 3

Nucleotide content and gene count levels of the genome

Attribute     Value     % of totala
Genome size (bp)     3,425,960     100
DNA coding region (bp)     3,115,812     90.94
DNA G+C content (bp)     2,398,172     70.00
Total genes     3,114     100
RNA genes     49     1.57
Protein-coding genes     3,064     98.39
Genes with function prediction     2,378     76.36
Genes assigned to COGs     2,077     66.69
Genes with peptide signals     181     5.8
Genes with transmembrane helices     317     10.17

a The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome

Figure 5

Graphical circular map of the genome. From outside to the center: genes on the forward strand (colored by COG categories), genes on the reverse strand (colored by COG categories), RNA genes (tRNAs, green; rRNAs, red), G+C content, GC skew.

Table 4

Number of genes associated with the 25 general COG functional categories

Code    Value   % of totala      Description
J    149   4.86      Translation
A    1   0.032      RNA processing and modification
K    163   5.31      Transcription
L    176   5.74      Replication, recombination and repair
B    0   0      Chromatin structure and dynamics
D    24   0.78      Cell cycle control, mitosis and meiosis
Y    0   0      Nuclear structure
V    47   1.53      Defense mechanisms
T    52   1.69      Signal transduction mechanisms
M    105   3.42      Cell wall/membrane biogenesis
N    0   0      Cell motility
Z    0   0      Cytoskeleton
W    0   0      Extracellular structures
U    26   0.84      Intracellular trafficking and secretion
O    76   2.47      Posttranslational modification, protein turnover, chaperones
C    139   4.53      Energy production and conversion
G    88   2.87      Carbohydrate transport and metabolism
E    189   6.16      Amino acid transport and metabolism
F    63   2.05      Nucleotide transport and metabolism
H    72   2.34      Coenzyme transport and metabolism
I    123   4.01      Lipid transport and metabolism
P    127   4.14      Inorganic ion transport and metabolism
Q    25   0.81      Secondary metabolites biosynthesis, transport and catabolism
R    250   8.15      General function prediction only
S    182   5.93      Function unknown
-    301   9.82      Not in COGs

a The total is based on the total number of protein coding genes in the annotated genome

a The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome Graphical circular map of the genome. From outside to the center: genes on the forward strand (colored by COG categories), genes on the reverse strand (colored by COG categories), RNA genes (tRNAs, green; rRNAs, red), G+C content, GC skew. a The total is based on the total number of protein coding genes in the annotated genome

Genomic comparison with and

Currently, two draft genomes from species are available. By comparison with strain BL2 (GenBank accession number AAGP00000000) and strain ATCC 49030 (ADNU00000000) B. senegalense strain JC43T has a smaller genome than the former (3.42 Mb vs 4.37Mb) but larger than the latter (2.56Mb). B. senegalense also has a higher G+C content than the other two genomes (70.00% vs 62.8% and 58.00%, respectively); it has a smaller number of predicted genes (3,114) than (4,054) but greater than (2,437). Finally, at the genome level, B. senegalense exhibited percentages of nucleotide sequence similarity of 86.28% (range 70.01-100%) and 70.19% (range 86.09-100%) with and , respectively.

Conclusion

On the basis of phenotypic (Table 5), phylogenetic and genomic analyses, we formally propose the creation of sp. nov. that contains the strain JC43T. This bacterium originated from Senegal.
Table 5

Phenotypic differences observed between B. senegalense strain JC43T, strain YIM90718 and strain TRM415.

    B. senegalense JC43T    B. album TRM415    B. salitolerans YIM90718
Motility    -    +    -
Catalase    +    +    +
Oxydase    -    -    -
Spore-forming    -    -    -
T° of growth    25-37°C    28-45°C    15-50°C
Gelatin hydrolysis    W    +    +
Alkaline phosphatase    +    +    +
Esterase lipase C8    +    +    NA
Pyrazinamidase    -    +    +
Nitrate reduction    +    -    -
β -glucuronidase    -    -    -
β - galactosidase    -    -    -
N-acetyl- β -glucosamidase    -    -    -
β -glucosidase (aesculin hydrolysis)    -    -    +
α-glucosidase    -    -    -
urease    -    -    -
Acid production for
D-ribose    -    +    +
D-glucose    -    -    -

Description of sp. nov.

(se.ne.gal.e’n.se L. gen. neutr. n. senegalense, pertaining to, or originating from Senegal, the country from which the specimen that enabled isolation of B. senegalense was isolated.) Colonies are translucent, smooth and have a diameter of 1 mm on blood-enriched Columbia agar and Brain Heart Infusion (BHI) agar. Cells are rod-shaped and occur mostly in small clumps. Their length and width range from 0.83 to 3.86 µm (mean, 2.55 µm) and 0.57 to 0.78 µm (mean, 0.68 µm), respectively. Optimal growth is achieved aerobically with or without CO2. Weak growth is observed under microaerophilic conditions. No growth is observed under anaerobic conditions. Growth occurs between 30-37°C. Cells stain Gram-positive, are non-endospore-forming, and non-motile. Catalase, nitrate reduction, pyrrolidonyl arylamidase, alkaline phosphatase, α-glucosidase, gelatin hydrolysis, esterase (C4), esterase lipase (C8), leucine arylamidase and acid and alkaline phosphatase activities are present. Urease, pyrazinamidase, β-glucuronidase, β-galactosidase, α-glucosidase, N-acetyl-β-glucosaminidase, β-glucosidase (aesculin hydrolysis), acid production from D-ribose, D-glucose, D-xylose, D-mannitol, maltose, D-lactose, sucrose and glycogen, valine aylamidase, cystine aylamidase, trypsin, α-chymotrypsin, naphtol-AS-BI-phosphohydrolase, lipase, α-galactosidase, β-galactosidase, β-glucuronidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase, α-mannosidase and α-fucosidase activities are absent. Oxidase activity is absent. Cells are susceptible to penicillin G, amoxicillin, imipenem, ciprofloxacin, rifampin, gentamicin, doxycycline and vancomycin, but resistant to trimethoprim/sulfamethoxazole and metronidazole. The G+C content of the genome is 70.00%. The 16S rRNA and genome sequences are deposited in EMBL under accession numbers JF824806 and CAHK00000000, respectively. The type strain JC43T (= CSUR P 155 = DSM 25783) was isolated from the fecal flora of a healthy patient in Senegal.
  29 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  Brevibacterium casei as a cause of brain abscess in an immunocompetent patient.

Authors:  V Anil Kumar; Deepthi Augustine; Dilip Panikar; Aswathy Nandakumar; Kavitha R Dinesh; Shamsul Karim; Rosamma Philip
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Piseth Seng; Michel Drancourt; Frédérique Gouriet; Bernard La Scola; Pierre-Edouard Fournier; Jean Marc Rolain; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

4.  Comprehensive census of bacteria in clean rooms by using DNA microarray and cloning methods.

Authors:  Myron T La Duc; Shariff Osman; Parag Vaishampayan; Yvette Piceno; Gary Andersen; J A Spry; Kasthuri Venkateswaran
Journal:  Appl Environ Microbiol       Date:  2009-08-21       Impact factor: 4.792

5.  Notes on the characterization of prokaryote strains for taxonomic purposes.

Authors:  B J Tindall; R Rosselló-Móra; H-J Busse; W Ludwig; P Kämpfer
Journal:  Int J Syst Evol Microbiol       Date:  2009-08-21       Impact factor: 2.747

6.  Brevibacterium salitolerans sp. nov., an actinobacterium isolated from salt-lake sediment.

Authors:  Tong-Wei Guan; Ke Zhao; Jing Xiao; Ying Liu; Zhan-Feng Xia; Xiao-Ping Zhang; Li-Li Zhang
Journal:  Int J Syst Evol Microbiol       Date:  2010-01-29       Impact factor: 2.747

Review 7.  Central venous catheter infection with Brevibacterium sp. in an immunocompetent woman: case report and review of the literature.

Authors:  S Ulrich; R Zbinden; M Pagano; M Fischler; R Speich
Journal:  Infection       Date:  2006-04       Impact factor: 3.553

8.  Non contiguous-finished genome sequence and description of Bacillus timonensis sp. nov.

Authors:  Sahare Kokcha; Ajay Kumar Mishra; Jean-Christophe Lagier; Matthieu Million; Quentin Leroy; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-07-20

9.  Non-contiguous finished genome sequence and description of Paenibacillus senegalensis sp. nov.

Authors:  Ajay Kumar Mishra; Jean-Christophe Lagier; Romain Rivet; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-09-24

10.  Genome sequence and description of Alistipes senegalensis sp. nov.

Authors:  Ajay Kumar Mishra; Gregory Gimenez; Jean-Christophe Lagier; Catherine Robert; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-07-20
View more
  47 in total

1.  Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample.

Authors:  A Pfleiderer; J-C Lagier; F Armougom; C Robert; B Vialettes; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

2.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Non contiguous-finished genome sequence and description of Bacillus massiliosenegalensis sp. nov.

Authors:  Dhamodharan Ramasamy; Jean-Christophe Lagier; Aurore Gorlas; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-06-05

4.  Non contiguous-finished genome sequence and description of Dielma fastidiosa gen. nov., sp. nov., a new member of the Family Erysipelotrichaceae.

Authors:  Dhamodharan Ramasamy; Jean-Christophe Lagier; Thi Tien Nguyen; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-06-13

5.  New Microbes New Infections promotes modern prokaryotic taxonomy: a new section "TaxonoGenomics: new genomes of microorganisms in humans".

Authors:  Pierre-Edouard Fournier; Michel Drancourt
Journal:  New Microbes New Infect       Date:  2015-06-09

6.  Virgibacillus senegalensis sp. nov., a new moderately halophilic bacterium isolated from human gut.

Authors:  E Seck; J Rathored; S Khelaifia; O Croce; C Robert; C Couderc; F Di Pinto; C Sokhna; D Raoult; J-C Lagier
Journal:  New Microbes New Infect       Date:  2015-10-03

7.  Non contiguous-finished genome sequence and description of Senegalemassilia anaerobia gen. nov., sp. nov.

Authors:  Jean-Christophe Lagier; Khalid Elkarkouri; Romain Rivet; Carine Couderc; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-02-25

8.  Non contiguous-finished genome sequence and description of Enterobacter massiliensis sp. nov.

Authors:  Jean-Christophe Lagier; Khalid El Karkouri; Ajay Kumar Mishra; Catherine Robert; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-02-22

9.  Non contiguous-finished genome sequence and description of Alistipes obesi sp. nov.

Authors:  Perrine Hugon; Dhamodharan Ramasamy; Jean-Christophe Lagier; Romain Rivet; Carine Couderc; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-02-25

10.  Non contiguous-finished genome sequence and description of Peptoniphilus senegalensis sp. nov.

Authors:  Ajay Kumar Mishra; Jean-Christophe Lagier; Thi-Tien Nguyen; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.